AU2623700A - Uses of vascular endothelial growth factor in the treatment of erectile dysfunction - Google Patents
Uses of vascular endothelial growth factor in the treatment of erectile dysfunctionInfo
- Publication number
- AU2623700A AU2623700A AU26237/00A AU2623700A AU2623700A AU 2623700 A AU2623700 A AU 2623700A AU 26237/00 A AU26237/00 A AU 26237/00A AU 2623700 A AU2623700 A AU 2623700A AU 2623700 A AU2623700 A AU 2623700A
- Authority
- AU
- Australia
- Prior art keywords
- subject
- growth factor
- vascular endothelial
- endothelial growth
- blood supply
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 title abstract 6
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title abstract 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title abstract 6
- 208000010228 Erectile Dysfunction Diseases 0.000 title abstract 3
- 201000001881 impotence Diseases 0.000 title abstract 3
- 230000036770 blood supply Effects 0.000 abstract 7
- 210000003899 penis Anatomy 0.000 abstract 5
- 210000004392 genitalia Anatomy 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F27—FURNACES; KILNS; OVENS; RETORTS
- F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
- F27D27/00—Stirring devices for molten material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Mechanical Engineering (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09234591 | 1999-01-21 | ||
| US09/234,591 US6706682B2 (en) | 1999-01-21 | 1999-01-21 | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| PCT/US2000/001535 WO2000043029A1 (en) | 1999-01-21 | 2000-01-21 | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2623700A true AU2623700A (en) | 2000-08-07 |
Family
ID=22882011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU26237/00A Abandoned AU2623700A (en) | 1999-01-21 | 2000-01-21 | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6706682B2 (enExample) |
| EP (1) | EP1150698B1 (enExample) |
| JP (1) | JP2003501345A (enExample) |
| AT (1) | ATE303818T1 (enExample) |
| AU (1) | AU2623700A (enExample) |
| CA (1) | CA2360058A1 (enExample) |
| DE (1) | DE60022478T2 (enExample) |
| DK (1) | DK1150698T3 (enExample) |
| WO (1) | WO2000043029A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6706682B2 (en) * | 1999-01-21 | 2004-03-16 | The Trustees Of Columbia University In The City Of New York | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| CA2386480A1 (en) * | 1999-10-01 | 2001-04-12 | Julie M. Miller | A method of treating erectile dysfunction |
| US20020032153A1 (en) * | 2000-03-10 | 2002-03-14 | Whitehouse Martha Jo | Methods and compositions for the treatment and prevention of erectile dysfunction |
| EP1365794A2 (en) * | 2000-07-21 | 2003-12-03 | Lue, Tom | Prevention and treatment of sexual arousal disorders |
| US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| WO2007138590A2 (en) * | 2006-05-30 | 2007-12-06 | Yossi Gross | Implantable pump for drug delivery to treat erectile dysfunction |
| US8152711B2 (en) * | 2007-03-21 | 2012-04-10 | Yossi Gross | Implantable peristaltic pump to treat erectile dysfunction |
| US7818062B2 (en) * | 2008-01-31 | 2010-10-19 | Ed Tech Medical Ltd. | Peristaltic pump for treatment of erectile dysfunction |
| US20120183519A1 (en) * | 2011-01-13 | 2012-07-19 | Biomet Biologics, Llc | Treatment of erectile dysfunction using platelet-rich plasma |
| WO2016112049A1 (en) | 2015-01-06 | 2016-07-14 | Cardiovascular Biotherapeutics, Inc. | Angiogenic treatment of ischemic heart disease |
| CA2976675A1 (en) * | 2015-02-16 | 2016-08-25 | Cardiovascular Biotherapeutics, Inc. | Therapeutic angiogenesis for treating erectile conditions |
| WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5236904A (en) | 1989-09-18 | 1993-08-17 | Senetek, Plc | Erection-inducing methods and compositions |
| US5652225A (en) * | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
| US5594032A (en) * | 1994-11-10 | 1997-01-14 | Gonzalez-Cadavid; Nestor F. | Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
| US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
| WO1999056785A2 (en) | 1998-05-01 | 1999-11-11 | University Of Pittsburgh | Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction |
| AU4077499A (en) | 1998-05-15 | 1999-12-06 | Glaxo Group Limited | Infrared thermography |
| US6706682B2 (en) * | 1999-01-21 | 2004-03-16 | The Trustees Of Columbia University In The City Of New York | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| CA2386480A1 (en) | 1999-10-01 | 2001-04-12 | Julie M. Miller | A method of treating erectile dysfunction |
-
1999
- 1999-01-21 US US09/234,591 patent/US6706682B2/en not_active Expired - Fee Related
-
2000
- 2000-01-21 DK DK00904485T patent/DK1150698T3/da active
- 2000-01-21 JP JP2000594482A patent/JP2003501345A/ja active Pending
- 2000-01-21 AU AU26237/00A patent/AU2623700A/en not_active Abandoned
- 2000-01-21 EP EP00904485A patent/EP1150698B1/en not_active Expired - Lifetime
- 2000-01-21 CA CA002360058A patent/CA2360058A1/en not_active Abandoned
- 2000-01-21 DE DE60022478T patent/DE60022478T2/de not_active Expired - Fee Related
- 2000-01-21 AT AT00904485T patent/ATE303818T1/de not_active IP Right Cessation
- 2000-01-21 WO PCT/US2000/001535 patent/WO2000043029A1/en not_active Ceased
-
2003
- 2003-09-09 US US10/658,991 patent/US20040048800A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2360058A1 (en) | 2000-07-27 |
| EP1150698B1 (en) | 2005-09-07 |
| ATE303818T1 (de) | 2005-09-15 |
| US6706682B2 (en) | 2004-03-16 |
| DE60022478T2 (de) | 2006-06-22 |
| JP2003501345A (ja) | 2003-01-14 |
| DE60022478D1 (de) | 2005-10-13 |
| EP1150698A1 (en) | 2001-11-07 |
| WO2000043029A1 (en) | 2000-07-27 |
| US20030124094A1 (en) | 2003-07-03 |
| US20040048800A1 (en) | 2004-03-11 |
| EP1150698A4 (en) | 2003-01-29 |
| DK1150698T3 (da) | 2006-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199700213A1 (ru) | Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений | |
| AU2623700A (en) | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction | |
| BR0112361A (pt) | Métodos para tratamento de condições oculares mediadas por inflamação | |
| EA200001044A2 (ru) | Соединения для лечения женской сексуальной дисфункции | |
| SG146666A1 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
| ATE229335T1 (de) | Heterozyklische bizykeln zur behandlung von impotenz | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| WO2004068931A3 (en) | Amphiregulin antibodies and their use to treat cancer and psoriasis | |
| AU4077701A (en) | Agent for use in method of treatment | |
| MY138883A (en) | Use of asiatic acid for treatment of cencer | |
| WO2002007749A3 (en) | Device providing regulated growth factor delivery for the regeneration of peripheral nerves | |
| EP1108426A3 (en) | Use of prostaglandin agonists to treat erectile dysfunction or impotence | |
| MY133446A (en) | Treatment of impotence due to spinal cord injury | |
| WO2002026245A3 (en) | Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions | |
| DE69800859D1 (de) | Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen | |
| WO1999024077A3 (en) | Compositions and methods for targeted delivery of biologically-active factors | |
| MY134288A (en) | Composition and its therapeutic use | |
| DE69924483D1 (de) | Kombinationstherapie zur behandlung von tumoren | |
| WO1999016406A3 (en) | Therapeutic method | |
| MD1119G2 (ro) | Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine | |
| AU1564500A (en) | Method for obtaining and using a combination of a purine and a nitrogen monoxidedonor for preventing or treating sexual dysfunction | |
| UA32241A (uk) | Спосіб лікування запалювальних процесів у експериментальних тварин | |
| UA10281C2 (uk) | Спосіб отримання речовини для лікування захворювань підшлункової залози | |
| MD1135F1 (en) | Paradontium treatment method | |
| MD1137G2 (ro) | Metodă de tratament al sterilităţii feminine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |